Dr. Thomas Lynch is appointed as the Sackler Professor
Dr. Thomas J. Lynch, the inaugural Richard Sackler and Jonathan Sackler Professor of Internal Medicine and Yale Cancer Center Director, is an expert on lung cancer. He also serves as the physician-in-chief of the new Smilow Cancer Hospital at Yale-New Haven
Lynch joined the Yale faculty in April 2009 after serving as professor of medicine at Harvard Medical School and chief of hematology/oncology at Massachusetts General Hospital (MGH) Cancer Center. He also was director of the Center for Thoracic Cancers at MGH and director of medical oncology at the MGH Thoracic Oncology Center.
A graduate of Yale College in 1982, he earned his M.D. degree from the Yale School of Medicine in 1986. He joined the medical staff at MGH in 1993. In 1996, he helped found the Boston-based Kenneth B. Schwartz Center for the Promotion of Caregiver/Patient Relations and became vice chair of its board of directors in 2006.
Lynch has made contributions in developmental therapeutics and in defining the optimal treatment for patients with lung cancer. He pioneered the use of molecular testing for mutations in the epidermal growth factor receptor gene to select patients who can benefit from targeted lung cancer therapies.
At Yale he will also oversee a new institute for cancer biology at the University’s West Campus, where scientists will investigate such areas as cell signaling, cancer immunology and drug development, and target acquisition.
The Smilow Cancer Hospital, a collaborative venture between the Yale School of Medicine and Yale-New Haven Hospital, is also committed to research and care that allows patients to receive personalized cancer therapy using molecular profiling.
The author of numerous publications, Lynch is also pursuing his own research on the causes and treatment of lung cancer.
In support of their interest in biomedical research, brothers Richard and Jonathan Sackler, through their respective family foundations, endowed the Richard and Jonathan Sackler Professorship and Director, Yale Cancer Center. The professorship is expressly intended to be held by those appointed as director of the Yale Cancer Center. The philanthropic spirit runs deep in the Sackler family; this recent commitment is an example of their desire to improve the human condition. Jonathan Sackler said, “In our philanthropy, we have looked for opportunities to support work by talented people that has the potential to positively affect the lives of millions of people. Yale’s biomedical research initiatives fit the bill.”